Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Traumatic brain injury (TBI) begins with the application of mechanical force to the head or brain, which initiates systemic and cellular processes that are hallmarks of the disease. The pathological cascade of secondary injury processes, including inflammation, can exacerbate brain injury-induced morbidities and thus represents a plausible target for pharmaceutical therapies. We have pioneered research on post-traumatic sleep, identifying that injury-induced sleep lasting for 6 h in brain-injured mice coincides with increased cortical levels of inflammatory cytokines, including tumor necrosis factor (TNF). Here, we apply post-traumatic sleep as a physiological bio-indicator of inflammation. We hypothesized the efficacy of novel TNF receptor (TNF-R) inhibitors could be screened using post-traumatic sleep and that these novel compounds would improve functional recovery following diffuse TBI in the mouse. METHODS: Three inhibitors of TNF-R activation were synthesized based on the structure of previously reported TNF CIAM inhibitor F002, which lodges into a defined TNFR1 cavity at the TNF-binding interface, and screened for in vitro efficacy of TNF pathway inhibition (IκB phosphorylation). Compounds were screened for in vivo efficacy in modulating post-traumatic sleep. Compounds were then tested for efficacy in improving functional recovery and verification of cellular mechanism. RESULTS: Brain-injured mice treated with Compound 7 (C7) or SGT11 slept significantly less than those treated with vehicle, suggesting a therapeutic potential to target neuroinflammation. SGT11 restored cognitive, sensorimotor, and neurological function. C7 and SGT11 significantly decreased cortical inflammatory cytokines 3 h post-TBI. CONCLUSIONS: Using sleep as a bio-indicator of TNF-R-dependent neuroinflammation, we identified C7 and SGT11 as potential therapeutic candidates for TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · cited 1×
“TNFR1 has been associated with inflammation and degeneration, whereas TNFR2 has been identified as neuroprotective [8, 9], for review see [10].”
BackgroundPathophysiology of traumatic brain injury
Werner, C., & Engelhard, K. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem131 · Cited by 1,712
The Role of Cytokines in Sleep Regulation
Krueger, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549281 · Cited by 507
Semple, B. D., Bye, N., Rancan, M., Ziebell, J. M., & Morganti-Kossmann, M. C. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.262 · Cited by 358
Bachstetter, A. D., Xing, B., de Almeida, L., Dimayuga, E. R., Watterson, D. M., & Van Eldik, L. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-79 · Cited by 282
Self-citationExploring new routes for neuroprotective drug development in traumatic brain injury
Janowitz, T., & Menon, D. K. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000330 · Cited by 74 · cited 3×
“Janowitz T, Menon DK. Exploring new routes for neuroprotective drug development in traumatic brain injury.”
InfluentialDiffuse brain injury does not affect chronic sleep patterns in the mouse
Rowe, R. K., Harrison, J. L., O’Hara, B. F., & Lifshitz, J. (2014) · Brain Injury · doi:10.3109/02699052.2014.888768 · Cited by 45 · cited 1×
“As expected, diffuse TBI resulted in a significant increase in the percent of post-traumatic sleep over the first 6 h post-injury in vehicle-treated mice compared to uninjured shams [23] (Fig.”
ResultSelf-citation
Cited by
Saber, M., Giordano, K. R., Hur, Y., Ortiz, J. B., Morrison, H., Godbout, J. P., Murphy, S. M., Lifshitz, J., & Rowe, R. K. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14611 · Cited by 46
Self-citationAcute Post-Traumatic Sleep May Define Vulnerability to a Second Traumatic Brain Injury in Mice
Rowe, R. K., Harrison, J. L., Morrison, H. W., Subbian, V., Murphy, S. M., & Lifshitz, J. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.5980 · Cited by 34
Self-citation
Metadata
- Authors
- Rowe, R. K., Harrison, J. L., Zhang, H., Bachstetter, A. D., Hesson, D. P., O’Hara, B. F., Greene, M. I., & Lifshitz, J.
- Venue
- Journal of Neuroinflammation
- Published
- 2018-05-22
- Volume
- 15
- Issue
- 1
- Pages
- 154-154
- ISSN
- 1742-2094 (ISSN-L)
- OpenAlex
- W2804273600
- Cited by
- 48
- References
- 7
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury. https://app.cochat.ai/papers/10.1186/s12974-018-1200-y
- The paper
- Rowe, R. K., Harrison, J. L., Zhang, H., Bachstetter, A. D., Hesson, D. P., O’Hara, B. F., Greene, M. I., & Lifshitz, J. (2018). Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-018-1200-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.